Newsroom

SITC is the world’s leading member society of medical professionals dedicated to advancing cancer immunotherapy and biological therapy through its initiatives, educational sessions, and collaborative endeavors. The society has become THE forum for innovative discussions in the field and remains a central provider of scientific information for its diverse members serving in academia, industry, and regulatory agencies in the U.S. and abroad.

Contact SITC staff today to find out how you can leverage our expertise for your articles and media efforts. 

You are encouraged to consult with SITC regarding:

• Recent advancements and breakthroughs in cancer immunotherapy, biological therapy and personalized medicine
• SITC meetings, educational sessions and programs
• General information about how immunotherapy and biological therapy are revolutionizing cancer patient treatment options
   

Society Representatives Available for Interviews:                                                                          

Thomas F. Gajewski, MD, PhD SITC President Professor, Department of Pathology, Sect. of Hematology/Oncology University of Chicago	Bernard A. Fox, PhD SITC Immediate Past President Chief, Laboratory of Molecular and Tumor Immunology Earle A. Chiles Research Institute
Michael B. Atkins, MD SITC Past President Deputy Chief, Division of Hematology/Oncology Beth Israel Deaconess Medical Center	Lisa H. Butterfield, PhD SITC Secretary/Treasurer Associate Professor of Medicine Surgery and Immunology University of Pittsburgh
Kim A. Margolin, MD SITC Member Professor, Division of Oncology University of Washington School of Medicine

Society for Immunotherapy of Cancer
formerly the International Society for Biological Therapy of Cancer
555 East Wells Street, Suite 1100 | Milwaukee, WI 53202-3823 USA
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: info@sitcancer.org

© 2012 Society for Immunotherapy of Cancer
All rights reserved